Philadelphia-based Endo sold its international pharma unit to Knight Therapeutics this week for up to $99 million, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback